Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-05-27 09:22 am Purchase | 13G | QUALIGEN THERAPEUTICS INC QLGN | ALPHA CAPITAL ANSTALT | 3,525,042 9.990% | 2,284,954 (+184.26%) | View |
| 2022-01-04 9:08 pm Sale | 13G | QUALIGEN THERAPEUTICS INC QLGN | SABBY MANAGEMENT LLC | 0 0.000% | -1,960,000 (Position Closed) | View |
| 2021-12-06 5:04 pm Purchase | 13G | QUALIGEN THERAPEUTICS INC QLGN | SABBY MANAGEMENT LLC | 1,960,000 11.000% | 1,960,000 (New Position) | View |
| 2020-06-01 5:00 pm Purchase | 13G | QUALIGEN THERAPEUTICS INC QLGN | SEKISUI DIAGNOSTICS LLC | 1,980,233 15.800% | 1,980,233 (New Position) | View |
| 2020-06-01 4:46 pm Purchase | 13G | QUALIGEN THERAPEUTICS INC QLGN | Greenblock Capital LLC | 811,431 6.500% | 811,431 (New Position) | View |
| 2020-05-28 4:05 pm Purchase | 13G | QUALIGEN THERAPEUTICS INC QLGN | ALPHA CAPITAL ANSTALT | 1,240,088 9.900% | 1,240,088 (New Position) | View |
| 2020-02-14 09:56 am Sale | 13G | QUALIGEN THERAPEUTICS INC QLGN | Alyeska Investment Group L.P. | 425,000 4.200% | -147,890 (-25.81%) | View |
| 2020-01-28 7:18 pm Sale | 13G | QUALIGEN THERAPEUTICS INC QLGN | Step Michael D | 128,757 0.700% | -820,077 (-86.43%) | View |
| 2020-01-28 4:15 pm Sale | 13G | QUALIGEN THERAPEUTICS INC QLGN | Stonehenge Partners LLC | 334,872 1.700% | -812,317 (-70.81%) | View |